Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Such an impressive Pipeline and NO IPO. Why not?
Or is this all window dressing? Doesn't appear so!
And where is this all going? What's it going to take?
https://www.zenithepigenetics.com/programs/pipeline
A head-scratcher alright ... Koo